Previous close | 0.1700 |
Open | 0.1750 |
Bid | 0.1750 x N/A |
Ask | 0.1800 x N/A |
Day's range | 0.1700 - 0.1800 |
52-week range | 0.1500 - 0.4247 |
Volume | |
Avg. volume | 158,988 |
Market cap | 80.613M |
Beta (5Y monthly) | 2.75 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0500 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 0.38 |
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
Microba Life Sciences ( ASX:MAP ) Full Year 2023 Results Key Financial Results Revenue: AU$5.42m (up 16% from FY 2022...
ColoAlert® Revenue Increases 108% Year Over Year in the First Six Months of 2023 ColoFuture and eAArly Detect Studies on Track to Report Results in September and in Q4, 2023 BERKELEY, Calif. and MAINZ, Germany, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the results of the first six months and second quarter ending June 30, 2023 and provi